Skip to main content
. Author manuscript; available in PMC: 2023 Aug 8.
Published in final edited form as: Adv Drug Deliv Rev. 2022 Sep 29;191:114564. doi: 10.1016/j.addr.2022.114564

Table 1.

Summary of NDD characterization studies discussed in this review.

Reference Sample Type Technique Result

[98] Postmortem ASD brain Bulk RNA First definition of molecular pathology in ASD or any psychiatric disorder. Identified ASD-associated neuronal immune-glial modules.
[65] Neurotypical fetal brain Bulk RNA ASD risk genes are enriched in neocortical development, most prominently glutamatergic layer 2/3 neurons.
[106] Neurotypical brain Bulk RNA Seeded networks from nine ASD genes identify dysregulation of deep layer projection neurons.
[108] Postmortem ASD brain miRNA Identified miRNAs and co-regulated modules perturbed in ASD
[91] Postmortem ASD brain H3K27ac ChIP-seq greater than 2/3 of syndromic and idiopathic ASD cases share a common acetylome signature
[76] Postmortem ASD brain Bulk RNA, miRNA, DNAm, H3K27ac Two ASD subtypes defined by transcriptomic and epigenetic signatures
[71] iPSC-derived ASD neurons Immunoprecipitation ASD perturbed genes are enriched in layer 2/3 cortical neurons
[36] iPSC-derived SCZ neurons Immunoprecipitation SCZ-perturbed genes are downregulated in layer 5/6 cortical neurons
[23] Postmortem ASD, BD, SCZ, and neurotypical brain Bulk RNA, Microarray Disease-specific and shared expression modules; Shared modules include increased inflammation and excitatory neuron signaling